SpaceX stock recovers 20% by Q4 2026 amid Ebola controversy

Despite initial drops following Musk’s USAID cuts, SpaceX stock will rebound by 20% or more by December 31, 2026, driven by strong commercial satellite and Starship program performance. The Ebola controversy is unlikely to significantly impact long-term investor confidence in SpaceX.

stocks · Prediction Market

Implied probability (Yes)

60%

Closes

2026-12-31

More stocks markets

• X Corp stock rises 8% within 3 months of SEC settlement approval — 70% Yes
• Robinhood stock rises 15% by 2027-01-31 due to Trump Accounts app — 65% Yes
• SpaceX IPO boosts Tesla’s institutional ownership by 5% by 2026-10-31 — 60% Yes
• Cruise line stock prices to recover by Q4 2026 — 65% Yes
• Canvas parent Instructure's stock drops 15% by June 2026 — 75% Yes
• Voi's stock rises 15% within 6 months of Pit's Series A announcement — 55% Yes
• Microsoft stock rises 10% or more by 2026-12-31 — 65% Yes
• Applied Materials stock rises above $250 by December 2026 — 68% Yes

Browse all stocks markets →